Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Workplace
Ephemeroptera
Salivary Gland Fistula
Radial head replacement with a bipolar system: an average 10-year follow-up.
CRISPR-mediated Sox9 activation and RelA inhibition enhance cell therapy for osteoarthritis.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CRISPR-mediated Sox9 activation and RelA inhibition enhance cell therapy for osteoarthritis.
CRISPR-mediated Sox9 activation and RelA inhibition enhance cell therapy for osteoarthritis. Mol Ther. 2024 Aug 07; 32(8):2549-2562.
View in:
PubMed
subject areas
Animals
Cartilage, Articular
Cell- and Tissue-Based Therapy
Chondrocytes
Chondrogenesis
CRISPR-Cas Systems
Disease Models, Animal
Gene Editing
Humans
Mesenchymal Stem Cell Transplantation
Mice
Osteoarthritis
SOX9 Transcription Factor
Transcription Factor RelA
authors with profiles
Lan Zhao